Skip to main content
Episurf logo

Episurf — Investor Relations & Filings

Ticker · EPIS ISIN · SE0003491562 LEI · 549300GORBCSMHZB2J75 ST Manufacturing
Open in API
Filings indexed 873 across all filing types
Latest filing 2019-08-28 Regulatory Filings
Country SE Sweden
Listing ST EPIS

About Episurf

https://episurf.com/

Episurf is a medical device company that develops and commercializes patient-specific solutions for treating painful joint injuries. The company's core technology utilizes 3D imaging to create personalized orthopedic implants and surgical instruments tailored to each patient's unique anatomy and cartilage defect. Its primary product line, the Episealer® system, provides minimally invasive implants for treating cartilage and underlying bone lesions in the knee and ankle joints. The objective of this individualized approach is to repair the joint, alleviate pain, and restore function, offering a treatment option for patients, often middle-aged, who are not yet candidates for total joint replacement surgery.

Recent filings

Filing Released Lang Actions
Episurf Medical tar nästa steg inom partnerskap avseende sin AI-baserade bildteknik
Regulatory Filings Classification · 95% confidence The document is a press release written in Swedish announcing that Episurf Medical has entered into an agreement with an American orthopedic company regarding the exclusive use of its AI-based medical imaging technology for allograft products in North America and the UK. It mentions this follows a Letter of Intent (LOI) from July 2019. The text concludes with a statement that this information is required to be made public under the EU Market Abuse Regulation (MAR) and specifies the release time (08:30 on August 28, 2019). This type of announcement, detailing a significant business development or partnership, is typically classified as a general regulatory announcement or a specific corporate action announcement. Since there is no specific category for 'Partnership Announcement' and it is a formal disclosure under MAR, it fits best under the general 'Regulatory Filings' (RNS) category, which serves as a fallback for miscellaneous regulatory disclosures not covered by other specific codes (like M&A, Financing, or Director's Dealing). Given the short length and nature as a formal disclosure, RNS is the most appropriate fit.
2019-08-28 Swedish
Episurf Medical takes the next step in partnership regarding its AI-based imaging technology
Regulatory Filings Classification · 100% confidence The document announces a significant business development: Episurf Medical entering into an agreement granting exclusive rights for its AI-based imaging technology in specific regions, following a previous Letter of Intent. This is a material event disclosure. It is not a full financial report (10-K, IR), an earnings release (ER), a management discussion (MDA), or a formal proxy/governance document. Since it details a strategic partnership and business development, it fits best under general Regulatory Filings (RNS) as a material event announcement, or potentially a general announcement if a more specific category like M&A (TAR) doesn't apply (which it doesn't, as it's a licensing/partnership agreement, not a takeover). Given the nature of disclosing a material agreement that impacts future revenue potential, RNS is the most appropriate general regulatory disclosure category for non-standard announcements.
2019-08-28 English
Change in number of shares and votes in Episurf Medical
Declaration of Voting Results & Voting Rights Announcements Classification · 99% confidence The document explicitly details a 'Change in number of shares and votes' following a new issue of shares, resulting in an increase in the total number of shares and share capital. This directly relates to changes in the company's capital structure and share count. This aligns perfectly with the definition for 'Share Issue/Capital Change' (SHA). The document is a formal notification of this event.
2019-07-31 English
Förändring av antalet aktier och röster i Episurf Medical
Share Issue/Capital Change Classification · 98% confidence The document explicitly discusses a change in the total number of shares and votes following a rights issue ('nyemission med företrädesrätt'). It details the increase in A-shares and B-shares, the new total share count, the new total vote count, and the increase in share capital. This directly relates to changes in the company's capital structure and share count. The most appropriate category is 'Share Issue/Capital Change' (SHA). It is not a general earnings release (ER), a dividend notice (DIV), or a director's dealing (DIRS). The final sentence mentions the obligation to disclose information according to financial instrument trading laws, confirming it is a formal regulatory disclosure regarding share structure.
2019-07-31 Swedish
Another US patent approval for Episurf Medical
Regulatory Filings Classification · 100% confidence The document announces a specific, non-financial corporate event: the approval of a US patent by the USPTO for a coating solution used in their joint implants. It is a brief press release format, not a comprehensive report (like 10-K or IR). It does not fit the definitions for AGM-R, 10-K, AR, MANG, CT, CAP, DVA, DLST, DIRS, ER, SR, FS, CGR, IRAT, IR, IP, LTR, TAR, MRQ, MDA, NAV, DIV, PSI, DEF 14A, RPA, SHA, or POS. Since it is a specific regulatory/corporate announcement that doesn't fit the highly specific categories, the most appropriate fallback is the general Regulatory Filings category (RNS). The document explicitly mentions compliance with the EU Market Abuse Regulation, confirming its nature as a required public disclosure.
2019-07-26 English
Ytterligare patentbeviljande i USA för Episurf Medical
Regulatory Filings Classification · 100% confidence The document is a short press release announcing a specific corporate event: the intention to grant an additional patent in the USA for Episurf Medical. It includes quotes, contact information, a brief company description, and a concluding statement about disclosure obligations under EU market abuse regulation, dated July 26, 2019. This is not a comprehensive financial report (like 10-K or IR), nor is it a transcript, management discussion, or formal voting result. It is a specific, non-financial regulatory announcement concerning intellectual property/corporate development. Since there is no specific category for 'Patent Grant Announcement,' and it is a formal disclosure required under market rules, it best fits the general 'Regulatory Filings' fallback category (RNS), as it is a material, non-financial announcement.
2019-07-26 Swedish

Browse filings by year

13 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.